SCHEMBL23707494

SCHEMBL23707494

CC(C(=O)O)N1CCC(Nc2ccnc3ccc(F)cc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 1/20 0.49
CDK9 P50750 1/20 0.49
IDO1 P14902 13/20 0.46
DYRK1A Q13627 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
MCHR1 Q99705 1/20 0.41
CYP2C9 P11712 3/20 0.40
CYP2C8 P10632 2/20 0.40
TDO2 P48775 2/20 0.40
CHRNA1 P02708 1/20 0.40
CYP2C19 P33261 1/20 0.40
CYP3A4 P08684 1/20 0.40
KCNH2 Q12809 1/20 0.40
GFER P55789 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KMT5B Q4FZB7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23707465 0.87 NOS2 (0.43) CCNT1CDK9IDO1KDM4EMEN1
SCHEMBL30444693 0.86 IDO1 (0.47) CCNT1CDK9IDO1CYP2C9
SCHEMBL23699073 0.86 IDO1 (0.47) CCNT1CDK9IDO1CYP2C9
SCHEMBL23699141 0.85 IDO1 (0.44) CCNT1CDK9IDO1
SCHEMBL23707445 0.84 IDO1 (0.57) IDO1CYP2C9CYP2C8TDO2CHRNA1
SCHEMBL23699153 0.83 IDO1 (0.48) CCNT1CDK9IDO1CYP2C9
SCHEMBL17729211 0.81 IDO1 (0.64) CCNT1CDK9IDO1
SCHEMBL23360560 0.80 GFER (0.48) IDO1CYP2C9CYP2C8TDO2GFER
SCHEMBL23360562 0.80 GFER (0.48) IDO1CYP2C9CYP2C8TDO2GFER
SCHEMBL23680443 0.79 IDO1 (0.56) IDO1CYP2C9CYP2C8TDO2CHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210379052-A1 QUINOLINE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITORY ACTIVITY SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. (CN) 2021-12-09 US disclosed
EP-3858813-A1 QUINOLONE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITED ACTIVITY Shenzhen Chipscreen Biosciences Co., Ltd. (CN) 2021-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210379052-A1 QUINOLINE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITORY ACTIVITY IDO1, IDO2, INMT CCNT1 3066/4885CDK9 1258/4885IDO1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.